Reuters logo
BRIEF-Aradigm Announces FDA Advisory Committee Meeting For Linhaliq
December 1, 2017 / 12:09 PM / 16 days ago

BRIEF-Aradigm Announces FDA Advisory Committee Meeting For Linhaliq

Dec 1 (Reuters) - Aradigm Corp:

* ARADIGM ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR LINHALIQ

* ARADIGM CORP - SUBMITTED NDA FOR LINHALIQ TO FDA IN JULY 2017, FOLLOWING WHICH FDA SET A PDUFA GOAL DATE OF JAN 26, 2018 FOR COMPLETION OF ITS REVIEW

* ARADIGM - MEETING OF ANTIMICROBIAL DRUGS ADVISORY COMMITTEE OF U.S. FDA SCHEDULED FOR JAN 11, 2018 TO REVIEW NEW DRUG APPLICATION FOR LINHALIQ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below